Last reviewed · How we verify
NCT04327804
A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research
trial testing Odd/Even birth year intervention groups in SARS-CoV Infection in 139 participants. Completed in 10 October 2020.
18 August 2020
Quick facts
| Lead sponsor | UnitedHealth Group |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 139 |
| Start date | 25 March 2020 |
| Primary completion | 18 August 2020 |
| Estimated completion | 10 October 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Odd/Even birth year intervention groups
Conditions studied
- SARS-CoV Infection — all drugs for SARS-CoV Infection →
Sponsor
UnitedHealth Group — full company profile →
Who can join
Eligibility, any sex, with SARS-CoV Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Minimal risk research study: 1. Comparing polyester nasal swabs and foam nasal swabs to detect SARS-CoV-2 virus; 2. Quantifying the development and trajectory of the disease through clinic visits and blood values.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19).
Verma HK, Merchant N, Verma MK, Kuru Cİ, et al · · 2020 · cited 21× · PMID 32792167 · DOI 10.1016/j.bj.2020.07.008
Verify or expand the search:
- PubMed search for NCT04327804
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SARS-CoV Infection
Currently open trials in the same condition.
- NCT05886816 — Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 · Phase 2 · recruiting
- NCT04802408 — SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial · Phase 2, PHASE3 · active not recruiting
- NCT04815096 — Imaging Immune Activation in COVID-19 · Phase 2 · recruiting
- NCT04747522 — Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) · active not recruiting
- NCT04579471 — Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study · recruiting
Other UnitedHealth Group trials
Trials by the same sponsor.
- NCT04810026 — Transform Type 2: Examining Meal-Delivery and Education for Diabetes Self-Care · NA · completed
- NCT04353037 — PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine · Phase 2 · terminated
- NCT04321369 — Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals · completed
- NCT01374646 — Community-based Program to Treat Childhood Obesity · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04327804 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by UnitedHealth Group
- Last refreshed: 11 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04327804.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing